Literature DB >> 2689112

Prevalence and significance of intrahepatic hepatitis delta virus antigen expression in HBeAg-negative patients with chronic type-B hepatitis in Taiwan.

C M Chu1, W C Shyu, Y F Liaw.   

Abstract

A consecutive series of 97 HBeAg-negative patients with chronic type-B hepatitis, who were not drug addicts or hemophiliacs, were examined for the prevalence of intrahepatic expression of hepatitis delta virus (HDV) antigen (HDAg) by direct immunofluorescence. The clinical and histological features were compared between those with and without intrahepatic HDAg expression. Intrahepatic HDAg expression was detected in 15 (15.5%) of the 97 patients. All of the 15 were males between 18 and 71 years of age. Each had elevated SGPT levels, with 46.8% being greater than 10 times normal and 73.4% greater than five times normal. Histological study revealed chronic lobular hepatitis in nine and chronic active hepatitis in six, including two with cirrhosis. Compared to the 82 patients without intrahepatic HDAg expression, no difference in the age (34.1 +/- 14.3 vs 36.7 +/- 10.8) and sex (15:0 vs 72:10) distribution was evident, but greater biochemical and histological activity was present in HDV-positive patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689112     DOI: 10.1007/bf01536711

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.

Authors:  M Rizzetto; R H Purcell; J L Gerin
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

2.  Delta agent infection in patients with chronic liver diseases and hepatocellular carcinoma--an infrequent finding in Taiwan.

Authors:  D S Chen; M Y Lai; J L Sung
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

3.  Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis.

Authors:  Y F Liaw; C M Chu; I J Su; M J Huang; D Y Lin; C S Chang-Chien
Journal:  Gastroenterology       Date:  1983-02       Impact factor: 22.682

4.  Infection with delta agent in Sweden: introduction of a new hepatitis agent.

Authors:  B G Hansson; T Moestrup; A Widell; E Nordenfelt
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

5.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

6.  Infection with the delta agent in chronic HBsAg carriers.

Authors:  A Smedile; P Dentico; A Zanetti; E Sagnelli; E Nordenfelt; G C Actis; M Rizzetto
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

7.  Correlation of age with the status of hepatitis B virus replication and histological changes in chronic type B hepatitis.

Authors:  C H Chu; Y F Liaw; I S Sheen; T J Chen
Journal:  Liver       Date:  1985-06

8.  Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.

Authors:  A Craxì; G Raimondo; G Longo; G Giannuoli; R De Pasquale; M Caltagirone; S Patti; G Squadrito; L Pagliaro
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

9.  Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum.

Authors:  C M Chu; P Karayiannis; M J Fowler; J Monjardino; Y F Liaw; H C Thomas
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

10.  Sex difference in chronic hepatitis B virus infection: an appraisal based on the status of hepatitis B e antigen and antibody.

Authors:  C M Chu; Y F Liaw; I S Sheen; D Y Lin; M J Huang
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.